Clinical Trial Update: Trial of Ibudilast for Methamphetamine Dependence [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ibudilast for methamphetamine dependence (with HIV infection) has completed and results were posted on January 30, 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Methamphetamine Dependence

Drugs mentioned

• ibudilast (ibudilast)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Methamphetamine Dependence, HIV Infection | Phase 2 | Status: COMPLETED | Results posted: 2019-01-30